CASE OF ACQUIRED COAGULOPATHY
In recent years, the number of patients receiving anticoagulant therapy worldwide is growing rapidly. This is due to the rapidly expanding scope of their application: an increasing number of patients with non-valvular heart disease, including atrial fibrillation, the risk of thromboembolic events, a...
Saved in:
Main Authors: | M. T. Vatutin, E. S. Gasendich, E. I. Iofe |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SINAPS LLC
2018-12-01
|
Series: | Архивъ внутренней медицины |
Subjects: | |
Online Access: | https://www.medarhive.ru/jour/article/view/859 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acquired Coagulopathies: Current Approaches to Differential Diagnosis and Intensive Care in the Context of Evidence-Based Medicine
by: S. V. Sinkov, et al.
Published: (2007-12-01) -
COVID-19-associated coagulopathy: a clinical case
by: K. M. Surmach, et al.
Published: (2022-12-01) -
Coagulopathy in the Acute Phase of Traumatic Brain Injury
by: A. I. Baranich, et al.
Published: (2020-03-01) -
COVID-19-associated coagulopathy in children and adolescents
by: M. V. Gomellya, et al.
Published: (2021-08-01) -
The Challenging Anticoagulant Therapy in Patient with COVID-19-Associated Coagulopathy
by: Raissa Virgy Rianda, et al.
Published: (2021-10-01)